• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗中性粒细胞胞质抗体相关性间质性肺疾病的临床特征和长期预后

Clinical features and long-term outcomes of interstitial lung disease with anti-neutrophil cytoplasmic antibody.

机构信息

Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China.

Peking University Institute of Haematology, Peking University People's Hospital, No. 11 Xizhimen South Street, Beijing, 100044, China.

出版信息

BMC Pulm Med. 2021 Mar 16;21(1):88. doi: 10.1186/s12890-021-01451-4.

DOI:10.1186/s12890-021-01451-4
PMID:33726733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7968287/
Abstract

BACKGROUND

Patients with interstitial lung disease (ILD) are occasionally positive for anti-neutrophil cytoplasmic antibodies (ANCAs). Differences between ILDs secondary to microscopic polyangiitis (MPA) and isolated ANCA-positive idiopathic interstitial pneumonia (IIP) remain unclear. The aim of this study was to explore the differences in clinical features and outcomes between MPA-associated ILDs and isolated ANCA-positive IIPs.

METHODS

We reviewed 1338 ILDs patients with available ANCA results and retrospectively analysed 80 patients who were ANCA-positive. MPA-associated ILDs (MPA-ILDs group) and isolated ANCA-positive IIPs (ANCA-IIPs group) were compared.

RESULTS

Among 80 patients with ANCA-positive ILDs, 31 (38.75%) had MPA-ILDs, and 49 (61.25%) had isolated ANCA-positive IIPs. Compared with ANCA-IIPs group, patients in MPA-ILDs group had a higher proportion of fever (p = 0.006) and higher neutrophil count (p = 0.011), erythrocyte sedimentation rate (ESR) (p < 0.001) and C-reactive protein (CRP) (p = 0.005). Multivariable analysis showed that ESR level was an independent risk factor for mortality in all 80 ANCA-positive ILDs patients (HR 1.028, p = 0.001). Survival in MPA-ILDs group was lower than that in ANCA-IIPs group, and further stratified analysis revealed that ANCA-IIPs patients with elevated ESR or CRP had a worse prognosis than those with normal inflammation markers, with 5-year cumulative survival rates of 60.00%, 86.90% and 100.00% in MPA-ILDs and ANCA-IIPs with and without elevated inflammation markers, respectively.

CONCLUSIONS

Among patients with ANCA-positive ILDs, the prognoses of ANCA-IIPs with normal inflammation markers, ANCA-IIPs with elevated inflammation markers and MPA-ILDs were sequentially poorer. Therefore, stratified treatment should be considered in the management of ILDs patients positive for ANCAs.

摘要

背景

间质性肺疾病(ILD)患者偶尔会出现抗中性粒细胞胞浆抗体(ANCAs)阳性。显微镜下多血管炎(MPA)继发的ILD 与单纯 ANCAs 阳性特发性间质性肺炎(IIP)之间的差异仍不清楚。本研究旨在探讨 MPA 相关 ILD 和单纯 ANCAs 阳性特发性间质性肺炎之间的临床特征和结局差异。

方法

我们回顾性分析了 1338 例可检测到 ANCAs 结果的 ILD 患者,其中 80 例 ANCAs 阳性。比较抗中性粒细胞胞浆抗体阳性的显微镜下多血管炎相关间质性肺疾病(MPA-ILDs 组)和单纯 ANCAs 阳性特发性间质性肺炎(ANCA-IIPs 组)。

结果

在 80 例 ANCAs 阳性的 ILD 患者中,31 例(38.75%)为 MPA-ILDs,49 例(61.25%)为单纯 ANCAs 阳性特发性间质性肺炎。与 ANCA-IIPs 组相比,MPA-ILDs 组发热(p=0.006)、中性粒细胞计数(p=0.011)、红细胞沉降率(ESR)(p<0.001)和 C 反应蛋白(CRP)(p=0.005)更高。多变量分析显示,ESR 水平是所有 80 例 ANCAs 阳性 ILD 患者死亡的独立危险因素(HR 1.028,p=0.001)。MPA-ILDs 组的生存率低于 ANCA-IIPs 组,进一步分层分析显示,ESR 或 CRP 升高的 ANCA-IIPs 患者预后比炎症标志物正常的患者差,5 年累积生存率分别为 MPA-ILDs 组 60.00%、ANCA-IIPs 组炎症标志物正常 86.90%、炎症标志物升高 100.00%。

结论

在 ANCAs 阳性的 ILD 患者中,炎症标志物正常的 ANCAs 阳性特发性间质性肺炎、炎症标志物升高的 ANCAs 阳性特发性间质性肺炎和 MPA-ILD 的预后依次更差。因此,在 ANCAs 阳性的 ILD 患者管理中应考虑分层治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd9/7968287/e878cdf07709/12890_2021_1451_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd9/7968287/bd452d006817/12890_2021_1451_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd9/7968287/e878cdf07709/12890_2021_1451_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd9/7968287/bd452d006817/12890_2021_1451_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd9/7968287/e878cdf07709/12890_2021_1451_Fig2_HTML.jpg

相似文献

1
Clinical features and long-term outcomes of interstitial lung disease with anti-neutrophil cytoplasmic antibody.抗中性粒细胞胞质抗体相关性间质性肺疾病的临床特征和长期预后
BMC Pulm Med. 2021 Mar 16;21(1):88. doi: 10.1186/s12890-021-01451-4.
2
Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias.特发性间质性肺炎中髓过氧化物酶-抗中性粒细胞胞质抗体的临床意义。
PLoS One. 2018 Jun 21;13(6):e0199659. doi: 10.1371/journal.pone.0199659. eCollection 2018.
3
Clinical significance of acute exacerbation in interstitial lung disease with antineutrophil cytoplasmic antibody: an indicator of poor prognosis.抗中性粒细胞胞质抗体相关性间质性肺疾病急性加重的临床意义:不良预后的指标。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221140974. doi: 10.1177/17534666221140974.
4
[The clinical features and prognosis of interstitial lung disease patients with positive anti-neutrophil cytoplasmic antibody].抗中性粒细胞胞浆抗体阳性的间质性肺疾病患者的临床特征及预后
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Apr 12;43(4):362-368. doi: 10.3760/cma.j.cn112147-20191205-00813.
5
[Clinical features and survival analysis of microscopic polyangiitis-associated interstitial lung disease:a retrospective study of 28 patients].显微镜下多血管炎相关间质性肺疾病的临床特征及生存分析:28例患者的回顾性研究
Zhonghua Jie He He Hu Xi Za Zhi. 2022 Oct 12;45(10):1022-1030. doi: 10.3760/cma.j.cn112147-20220208-00097.
6
Clinical differences among patients with myeloperoxidase-antineutrophil cytoplasmic antibody-positive interstitial lung disease.中性粒细胞胞浆抗体阳性间质性肺疾病患者的临床差异。
Clin Rheumatol. 2023 Feb;42(2):479-488. doi: 10.1007/s10067-022-06388-5. Epub 2022 Oct 4.
7
Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias.蛋白酶-3-抗中性粒细胞胞浆抗体在特发性间质性肺炎患者中的临床意义
Lung. 2016 Apr;194(2):235-42. doi: 10.1007/s00408-016-9851-x. Epub 2016 Feb 12.
8
MPO-ANCA-positive conversion and microscopic polyangiitis development in idiopathic interstitial pneumonia: a case report.特发性间质性肺炎中 MPO-ANCA 阳性转化和显微镜下多血管炎的发展:一例报告。
CEN Case Rep. 2023 Feb;12(1):39-44. doi: 10.1007/s13730-022-00717-y. Epub 2022 Jun 24.
9
Long-term survival, causes of death, and prognostic factors for mortality in patients with microscopic polyangiitis and those with anti-neutrophil cytoplasmic antibody-positive interstitial lung disease: A single-center retrospective study.显微镜下多血管炎和抗中性粒细胞胞浆抗体阳性间质性肺病患者的长期生存、死亡原因和死亡预后因素:一项单中心回顾性研究。
Int J Rheum Dis. 2023 Mar;26(3):446-453. doi: 10.1111/1756-185X.14532. Epub 2022 Dec 11.
10
CCL2 produced by CD68+/CD163+ macrophages as a promising clinical biomarker of microscopic polyangiitis-interstitial lung disease.由CD68+/CD163+巨噬细胞产生的CCL2作为显微镜下多血管炎-间质性肺病一种有前景的临床生物标志物。
Rheumatology (Oxford). 2021 Oct 2;60(10):4643-4653. doi: 10.1093/rheumatology/keab064.

引用本文的文献

1
Myeloperoxidase-Antibody Positivity and Progression to Microscopic Polyangiitis in Interstitial Lung Disease: A Case Series.间质性肺疾病中髓过氧化物酶抗体阳性与进展为显微镜下多血管炎:病例系列
Respirol Case Rep. 2025 Jul 9;13(7):e70271. doi: 10.1002/rcr2.70271. eCollection 2025 Jul.
2
Clinical significance of anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonia: a retrospective observational study.抗中性粒细胞胞浆抗体在特发性间质性肺炎中的临床意义:一项回顾性观察研究。
BMC Pulm Med. 2025 May 29;25(1):271. doi: 10.1186/s12890-025-03736-4.
3
Prevalence and clinical significance of anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis-associated interstitial lung disease.

本文引用的文献

1
Management of ANCA associated vasculitis.抗中性粒细胞胞质抗体相关性血管炎的治疗。
BMJ. 2020 Mar 18;368:m421. doi: 10.1136/bmj.m421.
2
Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis.特发性肺纤维化北美患者抗中性粒细胞胞浆抗体的流行率和临床意义。
Chest. 2019 Oct;156(4):715-723. doi: 10.1016/j.chest.2019.05.014. Epub 2019 Jun 7.
3
Antineutrophil Cytoplasmic Antibody-Associated Lung Fibrosis.抗中性粒细胞胞浆抗体相关性肺纤维化。
类风湿关节炎相关间质性肺疾病中抗中性粒细胞胞浆抗体的患病率及临床意义
BMC Pulm Med. 2025 Apr 14;25(1):177. doi: 10.1186/s12890-025-03644-7.
4
Risk factors for poor prognosis in ANCA-associated vasculitis with interstitial lung disease: a systematic review and meta-analysis.抗中性粒细胞胞浆抗体相关性血管炎合并间质性肺疾病预后不良的危险因素:一项系统评价和荟萃分析
Clin Rheumatol. 2025 Apr;44(4):1675-1689. doi: 10.1007/s10067-025-07378-z. Epub 2025 Feb 26.
5
Clinical Profiles, Survival, and Lung Function Outcomes in ANCA-Associated Interstitial Lung Disease: An Observational Study.抗中性粒细胞胞浆抗体相关间质性肺疾病的临床特征、生存率及肺功能转归:一项观察性研究
J Clin Med. 2025 Jan 3;14(1):229. doi: 10.3390/jcm14010229.
6
Poor prognostic factors for relapse of interstitial lung disease in microscopic polyangiitis: the Japanese multicentre REVEAL cohort study.显微镜下多血管炎中间质性肺病复发的不良预后因素:日本多中心REVEAL队列研究
Arthritis Res Ther. 2024 Dec 19;26(1):221. doi: 10.1186/s13075-024-03453-z.
7
Clinical features, radiological findings and prognosis of microscopic polyangiitis with interstitial lung disease: a retrospective matched control study.显微镜下多血管炎合并间质性肺疾病的临床特征、影像学表现及预后:一项回顾性配对对照研究
BMC Pulm Med. 2024 Dec 9;24(1):605. doi: 10.1186/s12890-024-03423-w.
8
Prevalence and characteristics of bronchiectasis in ANCA-associated vasculitis: A systematic review and meta-analysis.抗中性粒细胞胞浆抗体相关血管炎中支气管扩张的患病率及特征:一项系统评价和荟萃分析。
Arch Rheumatol. 2024 Feb 6;39(3):488-509. doi: 10.46497/ArchRheumatol.2024.10352. eCollection 2024 Sep.
9
Pathogenesis of Pulmonary Manifestations in ANCA-Associated Vasculitis and Goodpasture Syndrome.抗中性粒细胞胞质抗体相关性血管炎和 Goodpasture 综合征肺部表现的发病机制。
Int J Mol Sci. 2024 May 12;25(10):5278. doi: 10.3390/ijms25105278.
10
Comparison of Interstitial Lung Disease Between Antineutrophil Cytoplasmic Antibodies Positive and Negative Patients: A Retrospective Cohort Study.抗中性粒细胞胞浆抗体阳性与阴性患者间的间质性肺疾病比较:一项回顾性队列研究
ACR Open Rheumatol. 2024 Aug;6(8):463-469. doi: 10.1002/acr2.11679. Epub 2024 May 11.
Semin Respir Crit Care Med. 2018 Aug;39(4):465-470. doi: 10.1055/s-0038-1669914. Epub 2018 Nov 7.
4
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化诊断。美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.
5
Idiopathic Pulmonary Fibrosis.特发性肺纤维化
N Engl J Med. 2018 Aug 23;379(8):797-798. doi: 10.1056/NEJMc1807508.
6
Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias.特发性间质性肺炎中髓过氧化物酶-抗中性粒细胞胞质抗体的临床意义。
PLoS One. 2018 Jun 21;13(6):e0199659. doi: 10.1371/journal.pone.0199659. eCollection 2018.
7
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.特发性肺纤维化的诊断标准:弗利彻协会白皮书。
Lancet Respir Med. 2018 Feb;6(2):138-153. doi: 10.1016/S2213-2600(17)30433-2. Epub 2017 Nov 15.
8
Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis.特发性间质性肺炎与抗中性粒细胞胞浆抗体相关性间质性肺炎的临床特征比较。
Respirology. 2016 Jul;21(5):920-6. doi: 10.1111/resp.12763. Epub 2016 Mar 19.
9
The use of auto-antibody testing in the evaluation of interstitial lung disease (ILD)--A practical approach for the pulmonologist.自身抗体检测在间质性肺疾病(ILD)评估中的应用——呼吸科医生的实用方法。
Respir Med. 2016 Apr;113:80-92. doi: 10.1016/j.rmed.2016.01.019. Epub 2016 Feb 1.
10
Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias.蛋白酶-3-抗中性粒细胞胞浆抗体在特发性间质性肺炎患者中的临床意义
Lung. 2016 Apr;194(2):235-42. doi: 10.1007/s00408-016-9851-x. Epub 2016 Feb 12.